Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69K Sell
28
-32
-53% -$1.49K ﹤0.01% 2584
2026
Q1
$2.17K Hold
60
﹤0.01% 2394
2025
Q4
$2.83K Sell
60
-1
-2% -$42 ﹤0.01% 2380
2025
Q3
$1.98K Hold
61
﹤0.01% 2376
2025
Q2
$2.51K Sell
61
-5
-8% -$193 ﹤0.01% 2268
2025
Q1
$2.75K Buy
66
+5
+8% +$260 ﹤0.01% 2269
2024
Q4
$3.58K Hold
61
﹤0.01% 2060
2024
Q3
$4.21K Buy
+61
New +$3.94K ﹤0.01% 2019
2024
Q2
Sell
-32
Closed -$3.01K 1730
2024
Q1
$3.01K Buy
+32
New +$2.57K ﹤0.01% 2035
2022
Q4
$41.7K Buy
+610
New +$38.8K ﹤0.01% 1046
2022
Q3
Sell
-834
Closed -$52K 727
2022
Q2
$52K Buy
+834
New +$51.1K ﹤0.01% 922
2022
Q1
Sell
-5,669
Closed -$476K 738
2021
Q4
$476K Buy
+5,669
New +$454K 0.03% 379

Other funds holding BRKR

CoreCap Advisors's BRKR Position: Q2 2026 in Review

CoreCap Advisors reduced its Bruker (BRKR) stake by 53% in Q2 2026, selling an estimated $1.49K and leaving 28 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

CoreCap Advisors first reported a position in BRKR in Q4 2021 and has held it in 12 quarters since. The position peaked at $476K in Q4 2021. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • CoreCap Advisors held 28 shares of Bruker worth $1.69K as of Q2 2026.
  • CoreCap Advisors sold 32 Bruker shares in Q2 2026, an estimated $1.49K.
  • Bruker made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2584 holding.
  • CoreCap Advisors first reported a position in Bruker in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's Bruker position peaked at $476K in Q4 2021.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.